Therefore, we used the QUANTISEQ, XCELL, MCPCOUNTER and EPIC methods to analyse the relationship between RIPK2 and CD8+ T, T regulatory cells and cancer-related fibroblasts. The gene discussed is CD8A; the disease is cancer.